Supplemental_Material2.pdf (175.85 kB)
Supplemental Material2 - Supplemental material for Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
journal contribution
posted on 2019-09-04, 12:08 authored by Luisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, Lorenzo Bertani, Francesco Costa, Giuseppe Privitera, Barbara Tolusso, Clara Di Mario, Eleonora Albano, Gherardo Tapete, Elisa Gremese, Alfredo Papa, Antonio Gasbarrini, Gian Ludovico Rapaccini, Alessandro ArmuzziSupplemental material, Supplemental Material2 for Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease by Luisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, Lorenzo Bertani, Francesco Costa, Giuseppe Privitera, Barbara Tolusso, Clara Di Mario, Eleonora Albano, Gherardo Tapete, Elisa Gremese, Alfredo Papa, Antonio Gasbarrini, Gian Ludovico Rapaccini and Alessandro Armuzzi in United European Gastroenterology Journal